Twist Bioscience sinks 19% despite first positive EBITDA quarter as FY27 outlook disappoints
Investing.com · · AI-summarised by FinFlash
Twist Bioscience shares fell 19.35% to $98.87 from The sell-off shows investors punishing growth names whose guidance leans on unproven AI revenue; watch synthetic biology and tools peers for spillover. Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.So What?
Understand the context